Luca Grumolato

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Brain Metastases

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Nature communications

INSERM U1239-University of Rouen Normandie

University of Rouen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM U1239-University of Rouen Normandie

France

Assistant/Associate Professor

Icahn School of Medicine at Mount Sinai

United States

Instructor :: Oncological Sciences

Icahn School of Medicine at Mount Sinai

United States

Postdoctoral fellow :: Oncological Sciences

Education History

University of Rouen

France

PHD

Publications

Houssein Chhouri, David Alexandre, Luca Grumolato
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer. Cancers 15 (2) (2023)
Houssein Chhouri, David Alexandre, Luca Grumolato
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer. Cancers 15 (2) (2023)
Anita M Rogic, Ila Pant, Luca Grumolato, Ruben Fernandez-Rodriguez, Andrew Edwards, Suvendu Das, Aaron Sun, Shen Yao, Rui Qiao, Shabnam Jaffer, Ravi Sachidanandam, Guray Akturk, Rosa Karlic, Mihaela Skobe, Stuart A Aaronson
High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. Nature communications 12 (1) (2021)
Mirna Swayden, Houssein Chhouri, Youssef Anouar, Luca Grumolato
Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy. Cells 9 (12) (2020)